840857C

16:0-18:1 PA

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (sodium salt), chloroform

• Synonyme(s) : 1-hexadecanoyl-2--(9Z-octadecenoyl)-sn-glycero-3-phosphate (sodium salt); POPA; PA(16:0/18:1(9Z)); 110616
• Formule empirique (notation de Hill) : C₃₇H₇₀O₈PNa
• Numéro CAS: 169437-35-8
• Poids moléculaire : 696.91
• Numéro MDL: MFCD00672609
• Code UNSPSC : 12352211
• Nomenclature NACRES : NA.25

Propriétés

• Essai: >99% (TLC)
• Forme: liquid
• Conditionnement: pkg of 1 × 2.5 mL (840857C-25mg); pkg of 2 × 4 mL (840857C-200mg); pkg of 5 × 4 mL (840857C-500mg)
• Fabricant/nom de marque: Avanti Research^™ - A Croda Brand 840857C
• Concentration: 10 mg/mL (840857C-25mg); 25 mg/mL (840857C-200mg); 25 mg/mL (840857C-500mg)
• Type de lipide: phospholipids; cardiolipins
• Conditions d'expédition: dry ice
• Température de stockage: −20°C
• Chaîne SMILES: [H][C@@](COP([O-])(O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
• InChI: 1S/C37H71O8P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,35H,3-16,19-34H2,1-2H3,(H2,40,41,42);/q;+1/p-1/b18-17-;/t35-;/m1./s1
• Clé InChI: PPYXMAJBOKWTQX-RYRMQHSSSA-M

Description

Description générale

16:0-18:1 PA (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (sodium salt)/POPA) has eight oxygen atoms and one hydroxyl hydrogen atom. POPA is an anionic lipid.

Application

16:0-18:1 PA (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (sodium salt)) has been used to study its effects on the monogalactosyldiacylglycerol (MGDG) synthase activity of chloroplast envelope and in liposome Pull-Down Assay with the C2-like domain of SEIPIN.

Actions biochimiques/physiologiques

Phosphatidic acid (PA) serves as a precursor for phosphatidylcholine or phosphatidylserine. It is involved in influencing the membrane curvature and signaling.

Conditionnement

5 mL Clear Glass Sealed Ampule (840857C-200mg)

5 mL Clear Glass Sealed Ampule (840857C-25mg)

5 mL Clear Glass Sealed Ampule (840857C-500mg)

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informations sur la sécurité

• Pictogrammes: GHS06,GHS08
• Mention d'avertissement: Danger
• Mentions de danger: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• Conseils de prudence: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Classification des risques: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Organes cibles: Central nervous system, Liver,Kidney
• Classe de danger pour l'eau (WGK): WGK 3